Skip to main content

Table 1 CIA Treatment Regimen

From: Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis

Group N Treatment Dose
Group 1 10 control mAb 1 mg/week
Group 2 10 Anti-IL-6 1 mg/week
Group 3 10 Anti-IL-6 5 mg/week
  1. Mice received weekly IP injections for 10 weeks. Groups 1 and 2 received 200 μL sterile PBS containing the required dose. Group 3 received 1 mL sterile PBS (500 μL on 2 consecutive days) containing the required dose of anti-IL-6.